How many young women per 10,000 HPV vaccinations have required referral for specialist assessment following vaccination.

The information requested is not held centrally. However, as with all vaccines and medicines the Medicines and Healthcare products Regulatory Agency (MHRA) monitors and provides advice on the safety of the HPV vaccine in the UK. Since the introduction of the HPV vaccine in 2008 it has been used in millions of girls across the UK and around the world, and the MHRA continue to advise that the vaccine has a very good safety profile. The MHRA keeps the HPV vaccine under close and continual review and would take regulatory action if new evidence emerged which called into question the safety of the HPV vaccine or any other vaccine currently in use.